<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0376422</journal-id><journal-id journal-id-type="pubmed-jr-id">6405</journal-id><journal-id journal-id-type="nlm-ta">Pediatrics</journal-id><journal-id journal-id-type="iso-abbrev">Pediatrics</journal-id><journal-title-group><journal-title>Pediatrics</journal-title></journal-title-group><issn pub-type="ppub">0031-4005</issn><issn pub-type="epub">1098-4275</issn></journal-meta><article-meta><article-id pub-id-type="pmid">34385349</article-id><article-id pub-id-type="pmc">9837742</article-id><article-id pub-id-type="doi">10.1542/peds.2021-052273</article-id><article-id pub-id-type="manuscript">HHSPA1860632</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Deaths in children and adolescents associated with COVID-19 and MIS-C in the United States</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>McCormick</surname><given-names>David W.</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Richardson</surname><given-names>LaTonia Clay</given-names></name><degrees>PhD, MS</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Young</surname><given-names>Paul R.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Viens</surname><given-names>Laura J.</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Gould</surname><given-names>Carolyn V.</given-names></name><degrees>MD, MSCR</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Kimball</surname><given-names>Anne</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Pindyck</surname><given-names>Talia</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Rosenblum</surname><given-names>Hannah G.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Siegel</surname><given-names>David A.</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Vu</surname><given-names>Quan M.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Komatsu</surname><given-names>Ken</given-names></name><degrees>MPH</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Venkat</surname><given-names>Heather</given-names></name><degrees>DVM, MPH</degrees><xref rid="A3" ref-type="aff">c</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Openshaw</surname><given-names>John J.</given-names></name><degrees>MD</degrees><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Kawasaki</surname><given-names>Breanna</given-names></name><degrees>MPH</degrees><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Siniscalchi</surname><given-names>Alan J.</given-names></name><degrees>MPH, MS</degrees><xref rid="A7" ref-type="aff">g</xref></contrib><contrib contrib-type="author"><name><surname>Gumke</surname><given-names>Megan</given-names></name><degrees>MPH, CPH</degrees><xref rid="A8" ref-type="aff">h</xref></contrib><contrib contrib-type="author"><name><surname>Leapley</surname><given-names>Andrea</given-names></name><degrees>MPH</degrees><xref rid="A8" ref-type="aff">h</xref></contrib><contrib contrib-type="author"><name><surname>Tobin-D&#x02019;Angelo</surname><given-names>Melissa</given-names></name><degrees>MD, MPH</degrees><xref rid="A9" ref-type="aff">i</xref></contrib><contrib contrib-type="author"><name><surname>Kauerauf</surname><given-names>Judy</given-names></name><degrees>MPH</degrees><xref rid="A10" ref-type="aff">j</xref></contrib><contrib contrib-type="author"><name><surname>Reid</surname><given-names>Heather</given-names></name><degrees>BS, CHES</degrees><xref rid="A10" ref-type="aff">j</xref></contrib><contrib contrib-type="author"><name><surname>White</surname><given-names>Kelly</given-names></name><degrees>MPH, CPH</degrees><xref rid="A11" ref-type="aff">k</xref></contrib><contrib contrib-type="author"><name><surname>Ahmed</surname><given-names>Farah S.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A12" ref-type="aff">l</xref></contrib><contrib contrib-type="author"><name><surname>Richardson</surname><given-names>Gillian</given-names></name><degrees>MPH</degrees><xref rid="A13" ref-type="aff">m</xref></contrib><contrib contrib-type="author"><name><surname>Hand</surname><given-names>Julie</given-names></name><degrees>MSPH</degrees><xref rid="A13" ref-type="aff">m</xref></contrib><contrib contrib-type="author"><name><surname>Kirkey</surname><given-names>Kim</given-names></name><degrees>PhD, MPH</degrees><xref rid="A14" ref-type="aff">n</xref></contrib><contrib contrib-type="author"><name><surname>Larson</surname><given-names>Linnea</given-names></name><degrees>MPH</degrees><xref rid="A15" ref-type="aff">o</xref></contrib><contrib contrib-type="author"><name><surname>Byers</surname><given-names>Paul</given-names></name><degrees>MD</degrees><xref rid="A16" ref-type="aff">p</xref></contrib><contrib contrib-type="author"><name><surname>Garcia</surname><given-names>Ali</given-names></name><degrees>MPH</degrees><xref rid="A17" ref-type="aff">q</xref></contrib><contrib contrib-type="author"><name><surname>Ojo</surname><given-names>Mojisola</given-names></name><degrees>MPH</degrees><xref rid="A18" ref-type="aff">r</xref></contrib><contrib contrib-type="author"><name><surname>Zamcheck</surname><given-names>Ariela</given-names></name><degrees>DO</degrees><xref rid="A19" ref-type="aff">s</xref></contrib><contrib contrib-type="author"><name><surname>Lash</surname><given-names>Maura K.</given-names></name><degrees>RN, MPH</degrees><xref rid="A20" ref-type="aff">t</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Ellen H.</given-names></name><degrees>MD, MPH</degrees><xref rid="A20" ref-type="aff">t</xref></contrib><contrib contrib-type="author"><name><surname>Reilly</surname><given-names>Kathleen H.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A20" ref-type="aff">t</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Erica</given-names></name><degrees>MD, MPH</degrees><xref rid="A21" ref-type="aff">u</xref></contrib><contrib contrib-type="author"><name><surname>de Fijter</surname><given-names>Sietske</given-names></name><degrees>MS</degrees><xref rid="A22" ref-type="aff">v</xref></contrib><contrib contrib-type="author"><name><surname>Naqvi</surname><given-names>Ozair H.</given-names></name><degrees>MS</degrees><xref rid="A23" ref-type="aff">w</xref></contrib><contrib contrib-type="author"><name><surname>Harduar-Morano</surname><given-names>Laurel</given-names></name><degrees>PhD, MPH</degrees><xref rid="A24" ref-type="aff">x</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Burch</surname><given-names>Anna-Kathryn</given-names></name><degrees>MD</degrees><xref rid="A25" ref-type="aff">y</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>Adele</given-names></name><degrees>MD</degrees><xref rid="A26" ref-type="aff">z</xref></contrib><contrib contrib-type="author"><name><surname>Kolsin</surname><given-names>Jonathan</given-names></name><degrees>MPH</degrees><xref rid="A27" ref-type="aff">aa</xref></contrib><contrib contrib-type="author"><name><surname>Pont</surname><given-names>Stephen J.</given-names></name><degrees>MD, MPH</degrees><xref rid="A27" ref-type="aff">aa</xref></contrib><contrib contrib-type="author"><name><surname>Barbeau</surname><given-names>Bree</given-names></name><degrees>MPH</degrees><xref rid="A28" ref-type="aff">ab</xref></contrib><contrib contrib-type="author"><name><surname>Bixler</surname><given-names>Danae</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Reagan-Steiner</surname><given-names>Sarah</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Koumans</surname><given-names>Emilia H.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><collab>on behalf of the Pediatric Mortality Investigation Team</collab><xref rid="FN2" ref-type="author-notes">&#x02020;</xref></contrib></contrib-group><aff id="A1"><label>a</label>CDC COVID-19 Response Team</aff><aff id="A2"><label>b</label>Epidemic Intelligence Service, CDC</aff><aff id="A3"><label>c</label>Arizona Department of Health Services</aff><aff id="A4"><label>d</label>CDC Career Epidemiology Field Officer Program</aff><aff id="A5"><label>e</label>California Department of Public Health</aff><aff id="A6"><label>f</label>Colorado Department of Public Health and Environment</aff><aff id="A7"><label>g</label>State of Connecticut Department of Public Health</aff><aff id="A8"><label>h</label>Florida Department of Health</aff><aff id="A9"><label>i</label>Georgia Department of Public Health</aff><aff id="A10"><label>j</label>Illinois Department of Public Health</aff><aff id="A11"><label>k</label>Indiana Department of Health</aff><aff id="A12"><label>l</label>Kansas Department of Health and Environment</aff><aff id="A13"><label>m</label>Louisiana Department of Health</aff><aff id="A14"><label>n</label>Michigan Department of Health and Human Services</aff><aff id="A15"><label>o</label>Minnesota Department of Health</aff><aff id="A16"><label>p</label>Mississippi State Department of Health</aff><aff id="A17"><label>q</label>Nevada Department of Health and Human Services</aff><aff id="A18"><label>r</label>New Jersey Department of Health</aff><aff id="A19"><label>s</label>New York State Department of Health</aff><aff id="A20"><label>t</label>New York City Department of Health and Mental Hygiene</aff><aff id="A21"><label>u</label>North Carolina Department of Health and Human Services</aff><aff id="A22"><label>v</label>Ohio Department of Health</aff><aff id="A23"><label>w</label>Oklahoma State Department of Health</aff><aff id="A24"><label>x</label>Pennsylvania Department of Health</aff><aff id="A25"><label>y</label>South Carolina Department of Health and Environmental Control</aff><aff id="A26"><label>z</label>Tennessee Department of Health</aff><aff id="A27"><label>aa</label>Texas Department of State Health Services</aff><aff id="A28"><label>ab</label>Utah Department of Health.</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">Contributed equally as co-senior authors</p></fn><fn id="FN2"><label>&#x02020;</label><p id="P2">A complete list of members of the Pediatric Mortality Investigation Team appears in the <xref rid="APP1" ref-type="app">Appendix</xref>.</p></fn><fn fn-type="con" id="FN3"><p id="P3">Contributors&#x02019; Statement Page</p><p id="P4">Dr. McCormick coordinated and supervised data collection, collected data, drafted the initial manuscript, and reviewed and revised the manuscript.</p><p id="P5">Dr. Richardson performed all statistical analyses, assisted with drafting the initial manuscript, and reviewed and revised the manuscript.</p><p id="P6">Dr. Young coordinated and supervised data collection, collected data, and reviewed and revised the manuscript.</p><p id="P7">Dr. Viens designed data collection instruments, coordinated and supervised data collection, collected data, assisted with drafting the initial manuscript, and reviewed and revised the manuscript.</p><p id="P8">Dr. Gould, Dr. Reagan-Steiner, and Dr. Koumans coordinated and supervised data collection, reviewed and revised the manuscript, and critically reviewed the manuscript for important intellectual content.</p><p id="P9">Dr. Kimball and Dr. Rosenblum collected data, assisted with drafting the initial manuscript, and reviewed and revised the manuscript.</p><p id="P10">Dr. Pindyck coordinated and supervised data collection, assisted with drafting the initial manuscript, and critically reviewed the manuscript for important intellectual content.</p><p id="P11">Dr. Siegel assisted with drafting the initial manuscript and critically reviewed the manuscript for important intellectual content.</p><p id="P12">Dr. Vu collected data, carried out the initial analyses, and critically reviewed the manuscript for important intellectual content.</p><p id="P13">Ms. Barbeau, Dr. Burch, Dr. Byers, Ms. de Fijter, Mr. Garcia, Ms. Gumke, Ms. Hand, Dr. Harduar-Morano, Ms. Kauerauf, Dr. Kawasaki, Dr. Kirkey, Mr. Kolsin, Mr. Komatsu, Ms. Larson, Ms. Lash, Ms. Leapley, Dr. Lee, Dr. Lewis, Mr. Naqvi, Ms. Ojo, Dr. Openshaw, Dr. Pont, Ms. Reid, Dr. Reilly, Ms. Richardson, Mr. Siniscalchi, Dr. Tobin-D&#x02019;Angelo, Dr. Venkat, Dr. White, Dr. Wilson, and Dr. Zamcheck collected data and critically reviewed the manuscript for important intellectual content.</p><p id="P14">Dr. Bixler reviewed and revised the manuscript and critically reviewed the manuscript for important intellectual content.</p><p id="P15">All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.</p></fn><corresp id="CR1"><bold>Address correspondence to:</bold> David McCormick, Division of Vector-borne Disease, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO 80521, <email>yup1@cdc.gov</email>, 970-225-4272.</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>9</day><month>1</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>12</day><month>8</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>1</month><year>2023</year></pub-date><volume>148</volume><issue>5</issue><elocation-id>e2021052273</elocation-id><abstract id="ABS1"><sec id="S1"><title>Objective</title><p id="P16">To describe the demographics, clinical characteristics, and hospital course among persons &#x0003c;21 years of age with a SARS-CoV-2-associated death.</p></sec><sec id="S2"><title>Methods</title><p id="P17">We conducted a retrospective case series of suspected SARS-CoV-2-associated deaths in the United States in persons &#x0003c;21 years of age during February 12&#x02013;July 31, 2020. All states and territories were invited to participate. We abstracted demographic and clinical data, including laboratory and treatment details, from medical records and entered them into an electronic database.</p></sec><sec id="S3"><title>Results</title><p id="P18">We included 112 SARS-CoV-2 associated deaths from 25 participating jurisdictions. The median age was 17 years (interquartile range 8.5&#x02013;19 years). Most decedents were male (71, 63%), 31 (28%) were Black (non-Hispanic) persons, and 52 (46%) were Hispanic persons. Ninety-six decedents (86%) had at least one underlying condition; obesity (47/112, 42%), asthma (33/112, 29%), and developmental disorders (25/112, 22%) were most commonly documented. Among 69 hospitalized decedents, common complications included mechanical ventilation (45/60, 75%), acute respiratory failure (51/62, 82%), and acute renal failure (21/62, 34%). The sixteen (14%) decedents who met multisystem inflammatory syndrome in children (MIS-C) criteria were similar in age, gender, and race/ethnicity to decedents without MIS-C, and 11/16 (69%) had at least one underlying condition.</p></sec><sec id="S4"><title>Conclusion</title><p id="P19">SARS-CoV-2-associated deaths among persons &#x0003c;21 years of age during February&#x02013;July 2020 occurred predominantly among Black (non-Hispanic) and Hispanic persons, males, and older adolescents of all races/ethnicities. The most commonly reported underlying conditions were obesity, asthma, and developmental disorders. Decedents with COVID-19 disease were more likely than those with MIS-C to have underlying medical conditions.</p></sec></abstract><abstract id="ABS2" abstract-type="summary"><title>Article Summary</title><p id="P20">We report the clinical characteristics and hospital course of persons &#x0003c;21 years of age with SARS-CoV-2-associated deaths in the United States during February&#x02013;July, 2020.</p></abstract></article-meta></front><body><sec id="S5"><title>Introduction</title><p id="P21">In previously healthy individuals &#x0003c;21 years of age, infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is typically asymptomatic or mild, with recovery expected within 1&#x02013;2 weeks.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> An estimated 7% of children with COVID-19 are hospitalized<sup><xref rid="R3" ref-type="bibr">3</xref></sup>, and 28&#x02013;33% of hospitalized children require intensive care.<sup><xref rid="R3" ref-type="bibr">3</xref>&#x02013;<xref rid="R6" ref-type="bibr">6</xref></sup> While individuals &#x0003c;21 years of age made up less than 2% of reported COVID-19 cases, as of April 13, 2021, more than 2.8 million cases and 377 deaths associated with SARS-CoV-2 in U.S. children &#x0003c;18 years were reported to the United States Centers for Disease Control and Prevention (CDC).<sup><xref rid="R7" ref-type="bibr">7</xref></sup></p><p id="P22">Risk factors for death associated with COVID-19 among children are not well described.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref></sup> In adults, risk factors include older age, male sex, and underlying medical conditions, including obesity, immunosuppression, chronic lung disease, cardiovascular disease, neurologic disorders, and diabetes.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> In hospitalized children, the presence of underlying medical conditions increases the risk for severe illness from COVID-19.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup> In addition, children infected with SARS-CoV-2 can develop multi-system inflammatory syndrome (MIS-C), which predominantly affects previously healthy school-aged children.<sup><xref rid="R12" ref-type="bibr">12</xref></sup></p><p id="P23">Given the low number of SARS-CoV-2&#x02013;associated deaths among persons &#x0003c;21 years of age compared with adult deaths, limited information exists about the clinical course and underlying medical conditions among pediatric decedents. With the ongoing pandemic and increasing cases<sup><xref rid="R13" ref-type="bibr">13</xref></sup> and hospitalizations<sup><xref rid="R14" ref-type="bibr">14</xref></sup> in persons &#x0003c;21 years of age, we conducted an expanded review of data from an earlier study<sup><xref rid="R15" ref-type="bibr">15</xref></sup> to describe the demographics, clinical characteristics, and complications seen in children and adolescents with SARS-CoV-2 who died in the United States during February 12&#x02013;July 31, 2020.</p></sec><sec id="S6"><title>Methods</title><sec id="S7"><title>Case definition:</title><p id="P24">We defined a SARS-CoV-2&#x02013;associated pediatric death as a death occurring in a person &#x0003c;21 years of age with confirmed or probable COVID-19 and/or MIS-C and who died during February 12--July 31, 2020. The interim COVID-19 case definition published by the Council of State and Territorial Epidemiologists on August 5, 2020 was used to classify cases as confirmed or probable.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> Briefly, a case was classified as confirmed COVID-19 if there was a documented positive SARS-CoV-2 molecular amplification detection test, and classified as probable COVID-19 if the decedent 1) met clinical criteria and had epidemiologic evidence without confirmatory laboratory testing; 2) met presumptive laboratory evidence and either clinical or epidemiologic criteria; or 3) met vital records criteria without confirmatory lab testing performed. Cases met MIS-C criteria if they fulfilled the case definition published in the CDC Health Alert Network Health Advisory on May 14, 2020.<sup><xref rid="R17" ref-type="bibr">17</xref></sup></p></sec><sec id="S8"><title>Case Ascertainment, Data Collection, and Data Entry:</title><p id="P25">State and local health departments report confirmed or probable COVID-19 cases<sup><xref rid="R16" ref-type="bibr">16</xref></sup> to CDC as an element of the integrated national pandemic response. We examined case-based data for persons &#x0003c;21 years of age with confirmed or probable COVID-19 and/or MIS-C who died during the study period. We contacted health departments in all 50 states, New York City, the District of Columbia, Puerto Rico, Guam, and the US Virgin Islands (<italic toggle="yes">n</italic> = 55) to review the identified deaths and to invite jurisdictions with at least one identified SARS-CoV-2-associated pediatric death to participate in this study (<xref rid="F1" ref-type="fig">Figure 1</xref>). Classification of cases as SARS-CoV-2-associated deaths was determined by the individual jurisdictions.</p><p id="P26">Participating jurisdictions submitted demographic and clinical data on decedents abstracted from available medical records, death certificates, and autopsy reports. Clinical data included past medical history, presenting signs and symptoms, SARS-CoV-2 and other laboratory test results, clinical course and treatments received, location of death, and cause of death determination. Participating jurisdictions submitted information on all probable or confirmed SARS-CoV-2-associated deaths, as determined by the jurisdiction, in persons &#x0003c;21 years of age that occurred during the study period.</p><p id="P27">Information on decedents was collected and managed using REDCap (Research Electronic Data Capture)<sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup> hosted at CDC. Data were abstracted from available clinical charts and entered into a standardized REDCap form by either the participating jurisdictions (<italic toggle="yes">n</italic>=84) or CDC staff (<italic toggle="yes">n</italic>=28).</p></sec><sec id="S9"><title>Ethical Approval:</title><p id="P28">This activity was reviewed by CDC and was conducted consistent with applicable federal laws and CDC policy.<sup><xref rid="R20" ref-type="bibr">20</xref></sup></p></sec><sec id="S10"><title>Inclusion Criteria:</title><p id="P29">All cases of SARS-CoV-2-associated deaths in persons &#x0003c;21 years of age who died during the study period were considered for inclusion.</p></sec><sec id="S11"><title>Exclusion Criteria:</title><p id="P30">Decedents were excluded if the jurisdiction elected not to participate in the study (<italic toggle="yes">n</italic>=4); the clinical presentation, disease course, and pathologic findings after death were consistent with an etiology other than SARS-CoV-2 (<italic toggle="yes">n</italic>=2); or the decedents did not meet the confirmed or probable case definition (<italic toggle="yes">n</italic>=2; <xref rid="F1" ref-type="fig">Figure 1</xref>).</p></sec><sec id="S12"><title>Statistical Analysis:</title><p id="P31">Continuous variables are expressed as median and interquartile ranges (IQR) and categorial data are expressed as counts and percentages. We did not impute missing data, and decedents with missing information on the variable of interest were excluded from any analyses of that variable of interest. The Mann-Whitney <italic toggle="yes">U</italic> test was used to compare age and illness duration, and the &#x003c7;<sup>2</sup> test was used to compare all other variables. All statistical tests are two-sided and an &#x003b1;-value of 0.05 was considered significant. All statistical calculations were performed using SAS software Version 9.4 (SAS Institute, Cary, NC).</p><p id="P32">Laboratory measurements were converted to one standard unit of measure. Age- and gender-specific ranges for normal values and tachycardia were determined using the Harriet Lane Handbook<sup><xref rid="R21" ref-type="bibr">21</xref></sup> and the Seattle Children&#x02019;s Hospital&#x02019;s Department of Laboratories online laboratory testing catalogue<sup><xref rid="R22" ref-type="bibr">22</xref></sup>. We used the age-specific obesity cutoffs from CDC&#x02019;s BMI-for-Age charts<sup><xref rid="R23" ref-type="bibr">23</xref></sup> and the World Health Organization&#x02019;s age-specific cutoffs for tachypnea.<sup><xref rid="R24" ref-type="bibr">24</xref></sup></p><p id="P33">Deaths that occurred at home or in the emergency department were classified as &#x0201c;non-hospitalized,&#x0201d; and deaths that occurred after hospital admission were classified as &#x0201c;hospitalized.&#x0201d;</p></sec></sec><sec id="S13"><title>Results</title><p id="P34">Among the 55 jurisdictions invited to submit information, 47 responded. Twenty-five jurisdictions participated in the study, twenty jurisdictions reported no deaths, and two jurisdictions (representing 4 deaths) declined participation (<xref rid="F1" ref-type="fig">Figure 1</xref>). We identified 112 deaths associated with COVID-19 and/or MIS-C in persons &#x0003c;21 years for inclusion in this study, of which 108 (96%) were confirmed and 4 (4%) were probable COVID-19 cases. Sixteen decedents (15%) met MIS-C criteria. The first death was reported the week of March 15, 2020 (<xref rid="SD3" ref-type="supplementary-material">Supplementary Figure 1</xref>).</p><p id="P35">Most decedents were male (71/112, 63%, <xref rid="T1" ref-type="table">Table 1</xref>). The median age at death was 17 years (IQR 8.5&#x02013;19, range 1 month to 20 years, <xref rid="T1" ref-type="table">Table 1</xref>). Race/ethnicity was reported for 111 decedents (99%). Of these, there were 52 (47%) Hispanic, 31 (28%) Black (non-Hispanic), 16 (14%) White (non-Hispanic), 5 (5%) American Indian or Alaska Native (non-Hispanic), 5 (5%) Asian/Pacific Islander (non-Hispanic), and 2 (2%) persons who identified as non-Hispanic of another race or of more than one race (<xref rid="T1" ref-type="table">Table 1</xref>). Decedents with MIS-C had similar age, gender, and race/ethnicity distributions as those without MIS-C (<xref rid="T2" ref-type="table">Table 2</xref>).</p><p id="P36">A death certificate was available for 74 (66%) decedents. COVID-19 was reported as the underlying cause of death in 48 (65%) and as a contributing factor in 21 (28%) decedents (<xref rid="T3" ref-type="table">Table 3</xref>). These decedents had similar age, sex, race/ethnicity, and underlying conditions as decedents without available information. The location of death was reported for 111 decedents (99%); 69 (62%) died in the hospital, 23 (21%) decedents died in the emergency department, 18 (16%) died at home, and one (1%) died in hospice care. Among decedents with MIS-C, 1/16 (6%) died at home or in the emergency department compared with 34/80 (43%) decedents without MIS-C (<italic toggle="yes">p</italic>=0.037).</p><p id="P37">Information on underlying medical conditions was available for all decedents (<xref rid="T4" ref-type="table">Table 4</xref>; <xref rid="SD3" ref-type="supplementary-material">Supplemental Figure 2</xref>); 96 decedents (86%) had at least one underlying medical condition, including 50 (52%) with &#x02265;3 underlying medical conditions and 25 (26%) with &#x02265;5 underlying medical conditions. The most commonly documented conditions were obesity (47, 42%), asthma or reactive airway disease (33, 29%), and developmental disorders (25, 22%). Thirteen decedents (12%) had an active malignancy, of which 8 (7%) were hematologic. Eighteen decedents (16%) were dependent on a gastrostomy tube for nutrition prior to illness onset. A higher proportion of decedents without MIS-C had at least one underlying condition (70/80, 87%) than decedents with MIS-C (11/16, 69%) (p = 0.06).</p><p id="P38">Among the 16 decedents with no underlying medical conditions, 12 (75%) were male. Eight (50%) were Hispanic, 5 (31%) were Black (non-Hispanic), 2 (13%) were White (non-Hispanic), and 1 (6%) was Hawaiian/Pacific Islander/Asian (non-Hispanic). These decedents were younger than decedents with underlying medical conditions (median age 2 years [IQR 0.75&#x02013;12 years] vs median age 17 years [IQR 12&#x02013;19 years], <italic toggle="yes">p</italic>&#x0003c;0.001). Five had MIS-C (31%) compared to 11/96 (11%, p=0.13) among all other decedents, and 11 (69%) died at home or in the emergency department compared to 30/96 (31%, p=0.02) among all other decedents. Four (25%) had been seen in an ambulatory or urgent care setting prior to death. The location of exposure to COVID-19 was available for 46 decedents (41%). The most common location for reported exposure was the decedent&#x02019;s household (33, 72%).</p><p id="P39">Data on reported symptoms were available for 67/80 (84%) decedents without MIS-C and 14/16 (88%) decedents with MIS-C (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table 1</xref>). The most commonly reported symptoms for decedents without MIS-C were fever (44/67, 66%), dyspnea (36/67, 54%), cough (34/67, 51%), nausea/vomiting (18/67, 27%), and fatigue (17/67, 25%); the most commonly reported symptoms for decedents with MIS-C (besides fever, which is part of the case definition for MIS-C) were cough (10/14, 71%), nausea/vomiting (10/14, 71%), dyspnea (6/14, 43%), loss of appetite (6/14, 43%), dehydration (6/14, 43%), and nasal congestion (5/14, 36%).</p><p id="P40">Among 98 (88%) decedents with a recorded symptom onset date, the median illness duration (time from symptom onset to death) was 11 days (IQR 7&#x02013;23 days). Among 99 decedents with a recorded SARS-CoV-2 viral detection test date, the median time from a first positive test to death was 8 days (IQR 3&#x02013;20 days). Decedents with MIS-C had a similar illness duration as those without MIS-C (median 11 days [IQR 6&#x02013;27 days] vs. median 11 days [IQR 7&#x02013;23 days], respectively) and had a similar time from first positive SARS-CoV-2 test to death compared to those without MIS-C (median 7 days [IQR 3&#x02013;24 days] vs. median 8 days [IQR 7&#x02013;23 days], respectively).</p><p id="P41">Non-hospitalized decedents (41, 37%) had similar age, gender, and race distributions compared with hospitalized decedents (69, 63%) (<xref rid="SD4" ref-type="supplementary-material">Supplementary Table 2</xref>). Non-hospitalized decedents had a shorter illness duration than hospitalized decedents (non-hospitalized: median 7 days, IQR 1&#x02013;12 days; hospitalized: median 13 days, IQR 9&#x02013;27 days; <italic toggle="yes">p</italic>&#x0003c;0.0001).</p><p id="P42">Among the 69 hospitalized decedents, the median number of days from symptom onset to hospital admission was 4 (IQR 2&#x02013;7 days) and the median number of days from initial hospitalization to death was 9 (IQR 4&#x02013;9 days). Fifteen (22%) met MIS-C criteria, 44 (64%) did not meet MIS-C criteria, and MIS-C status was unknown for 10 (14%) decedents MIS-C status. Fifty-five (80%) were admitted to the intensive care unit (ICU) at a median of 0 days (IQR 0&#x02013;1 day) after hospitalization; the median duration from ICU admission to death was 8 days (IQR 3&#x02013;13 days).</p><p id="P43">Vital signs at the time of presentation were available for 53/69 decedents (77%) who died after hospitalization (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>), including 37/44 (84%) without MIS-C, 13/15 (87%) with MIS-C, and 3/10 (30%) with unknown MIS-C status. The prevalence of fever, tachycardia, and tachypnea were similar between decedents with MIS-C and those without MIS-C.</p><p id="P44">Laboratory studies were available for 40/69 (58%) decedents who died after hospitalization (<xref rid="SD3" ref-type="supplementary-material">Supplementary Table 4</xref>). Common findings included thrombocytopenia (32/40, 80%), elevated procalcitonin (18/40, 45%), and elevated ferritin (21/40, 53%). Laboratory studies for decedents with MIS-C were similar to decedents without MIS-C. Among the 60 decedents who died after hospitalization with available information on hospital course and therapeutics, 45 were intubated and required mechanical ventilation (75%) and 8 received extracorporeal membrane oxygenation therapy (13%, <xref rid="T5" ref-type="table">Table 5</xref>). One-quarter of decedents (15) who died after hospitalization received immunomodulatory therapy, and 21 (35%) received remdesivir.</p><p id="P45">Information on complications was available for 62 (90%) hospitalized decedents. The most commonly reported complications were acute respiratory failure (51, 82%), shock (35, 56%), acute respiratory distress syndrome (31, 50%), sepsis (25, 40%), and acute renal failure (21, 34%) (<xref rid="T5" ref-type="table">Table 5</xref>).</p></sec><sec id="S14"><title>Discussion</title><p id="P46">Deaths associated with SARS-CoV-2 among individuals &#x0003c;21 years of age during February&#x02013;July 2020 occurred predominantly among older adolescents, males, Black (non-Hispanic) and Hispanic persons, and persons with underlying medical conditions. Persons &#x0003e;15 years of age constituted 58% of deaths in this study, while persons &#x0003c;1 year of age constituted only 7% of deaths, which contrasts with other studies that have shown the highest numbers of deaths in both infants and older adolescents.<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> The predominance of males among the decedents in this study is consistent with previous studies, which found male sex as a risk factor for more severe illness among both children and adults with COVID-19.<sup><xref rid="R27" ref-type="bibr">27</xref></sup></p><p id="P47">The COVID-19 pandemic has amplified racial and ethnic disparities in health, with Black (non-Hispanic) and Hispanic adults having higher rates of hospitalization due to COVID-19 than White (non-Hispanic) adults<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup> and Black (non-Hispanic) and Hispanic children and adolescents having increased risk of severe COVID-19 illness and MIS-C compared to White (non-Hispanic) children and adolescents.<sup><xref rid="R30" ref-type="bibr">30</xref>&#x02013;<xref rid="R32" ref-type="bibr">32</xref></sup> The majority of decedents in this study were Black (non-Hispanic) or Hispanic, providing further evidence of these disparities. Improving the health outcomes of populations disproportionately affected will require focused and ongoing strategies to address historical and contemporary injustices, and to eliminate health and healthcare disparities.<sup><xref rid="R33" ref-type="bibr">33</xref></sup></p><p id="P48">The proportion of decedents in this study with at least one underlying condition is much higher than in the general pediatric population.<sup><xref rid="R34" ref-type="bibr">34</xref>&#x02013;<xref rid="R37" ref-type="bibr">37</xref></sup> Developmental disorders are more prevalent among White (non-Hispanic) children compare to other racial and ethnic groups<sup><xref rid="R34" ref-type="bibr">34</xref></sup>, and obesity is more prevalent among Hispanic children than White (non-Hispanic) or Black (non-Hispanic) children.<sup><xref rid="R35" ref-type="bibr">35</xref></sup> Children and adolescents with multiple underlying medical conditions, including those with complex medical needs, are at increased risk for severe disease, hospitalization, and death from COVID-19.<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R38" ref-type="bibr">38</xref></sup> Obesity and neurologic and developmental conditions were common in this study; prior studies show that children with obesity and children with intellectual disabilities and seizure disorders have increased risk of both requiring critical care<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> and death associated with COVID-19.<sup><xref rid="R39" ref-type="bibr">39</xref>,<xref rid="R40" ref-type="bibr">40</xref></sup></p><p id="P49">Most reported exposures among decedents in this study occurred in the household, which is consistent with transmission studies conducted outside of the United States.<sup><xref rid="R41" ref-type="bibr">41</xref></sup> Notably, this study occurred during the first 6 months of the pandemic in the United States, when many students were enrolled in remote learning and stay-at-home orders were in place in some locations around the country.<sup><xref rid="R42" ref-type="bibr">42</xref></sup> While classrooms appear to be a low-risk setting for SARS-CoV-2 transmission<sup><xref rid="R43" ref-type="bibr">43</xref>&#x02013;<xref rid="R46" ref-type="bibr">46</xref></sup>, some studies have suggested an increased role for transmission in children and adolescents outside of the home as they have resumed other activities and stay-at-home orders are lifted in some jurisdictions.<sup><xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R48" ref-type="bibr">48</xref></sup> However, returning to face-to-face instruction may increase the risk of infection with SARS-CoV-2 and death in this population as in-person contact increases the risk of SARS-CoV-2 transmission.</p><p id="P50">Only 14% of decedents in this study met MIS-C criteria. Non-MIS-C COVID-19 represents a much higher contribution to SARS-CoV-2-associated mortality in this age group. Among those with MIS-C, a higher proportion were previously healthy decedents compared with those without MIS-C, consistent with other studies.<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup> However, it is important to note that MIS-C criteria at the time of this study included severe illness requiring hospitalization, which likely contributes to the high proportions of persons with MIS-C who died after hospitalization.</p><p id="P51">Acute respiratory failure, shock, and acute renal failure were relatively common complications among decedents (<xref rid="T5" ref-type="table">Table 5</xref>). A high proportion of decedents admitted to the hospital required mechanical ventilation. Immunomodulatory therapy was relatively common, even for decedents who did not have MIS-C, and remdesivir was administered to nearly one-third of hospitalized children. The use of immunomodulatory therapy in pediatric patients without MIS-C is not recommended in current guidelines.<sup><xref rid="R49" ref-type="bibr">49</xref></sup> These results provide insight into treatment practices in severely ill children and adolescents in the early phase of the pandemic before updated recommendations were established and should not be taken as treatment recommendations.</p><sec id="S15"><title>Limitations</title><p id="P52">This study has at least six limitations. First, there was no comparison group of children and adolescents who survived COVID-19 in this study, so we are unable to describe risk factors for death. Second, in some cases, death may have been incidentally associated with SARS-CoV-2 infection. Causal inference is difficult in descriptive studies and it is not always possible to determine whether decedents died from COVID-19 or died of other causes with active SARS-CoV-2 infection. However, a recent report found that death certificates provide accurate data for COVID-19 mortality surveillance.<sup><xref rid="R50" ref-type="bibr">50</xref></sup> Third, complete medical records, including laboratory data, were not available for all decedents. Fourth, data were entered by multiple abstractors, which may introduce data entry inconsistencies. Fifth, we do not have data on the number of COVID-19 cases in each age group during this period and cannot calculate case fatality rates or perform age-adjustment. Finally, this case series was assembled during the first six months of the pandemic prior to the emergence of multiple novel variants of concern and rapid expansion of vaccination. The combination of new variants of concern and increased rates of vaccination is likely to result in different symptomatology, illness severity, and case fatality than described here.</p></sec></sec><sec id="S16"><title>Conclusions</title><p id="P53">In this case series of individuals &#x0003c;21 years of age with SARS-CoV-2-associated deaths, most decedents were older adolescents or young adults and members of racial/ethnic minority groups. Obesity, developmental disorders, and asthma were the most commonly reported underlying conditions. Persons &#x0003c;21 years of age with COVID-19 disease resulting in death frequently had underlying medical conditions, while decedents with MIS-C were more likely to have no underlying medical conditions than decedents who did not meet MIS-C criteria. Acute respiratory failure requiring mechanical ventilation, shock, and cardiac arrythmias were common complications during hospitalization. Pediatric providers who care for children with complex medical needs should continue to counsel families about the importance of preventive behaviors and the risk for severe COVID-19, as well as to seek medical attention early if they develop COVID-19-like symptoms. These children may be at increased risk of decompensation during hospitalization and should be monitored closely if admitted to the hospital. Vaccination is available for persons &#x0003e;11 years of age and vaccine uptake will be a critical intervention to prevent COVID-19 mortality in this age group.<sup><xref rid="R51" ref-type="bibr">51</xref></sup> Continued assessment of pediatric and adolescent deaths as the pandemic continues is critical to understanding disease and mortality in this population.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplementary Table 3</label><media xlink:href="NIHMS1860632-supplement-Supplementary_Table_3.docx" id="d64e941" position="anchor"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data"><label>Supplementary Table 1</label><media xlink:href="NIHMS1860632-supplement-Supplementary_Table_1.docx" id="d64e944" position="anchor"/></supplementary-material><supplementary-material id="SD3" position="float" content-type="local-data"><label>Supplemental Material</label><media xlink:href="NIHMS1860632-supplement-Supplemental_Material.docx" id="d64e947" position="anchor"/></supplementary-material><supplementary-material id="SD4" position="float" content-type="local-data"><label>Supplementary Table 2</label><media xlink:href="NIHMS1860632-supplement-Supplementary_Table_2.docx" id="d64e950" position="anchor"/></supplementary-material></sec></body><back><ack id="S17"><title>Acknowledgements</title><p id="P54">Thank you to Jessica Leung for providing SAS code to assist with converting laboratory variables to one standard unit of measure.</p><sec id="S18"><title>Funding/Support:</title><p id="P55">This work was conducted as part of the US Centers for Disease Control and Prevention&#x02019;s COVID-19 response.</p></sec></ack><fn-group><fn fn-type="COI-statement" id="FN4"><p id="P59"><bold>Conflict of Interest Disclosures:</bold> The authors have no conflicts of interest relevant to this article to disclose.</p></fn><fn id="FN5"><p id="P60">The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.</p></fn></fn-group><app-group><app id="APP1"><title>Appendix</title><p id="P56">Here are the members of the Pediatric Mortality Investigation Team:</p><p id="P57">Ryan Manos<sup>a</sup>, MPH, Xandy Peterson Pompa<sup>a</sup>, MPH, Chloe Le Marchand<sup>b</sup>, MD, MSc, Caterina Y. Liu<sup>b</sup>, MD, MPH, Nnenna Okoye<sup>b</sup>, MD, MPH, Steve Moon<sup>c</sup>, Nisha Alden<sup>d</sup>, MPH, Isaac Armistead<sup>d</sup>, MD, MPH, Rachel Herlihy<sup>d</sup>, MD, MPH, Melissa Ivey<sup>e</sup>, MPH, Eric Hawkins<sup>f</sup>, Justin Blanding<sup>g</sup>, MPH, Stacy Holzbauer<sup>h</sup>, DVM, MPH, Leslie Kollman<sup>h</sup>, BS, Ruth Lynfield<sup>h</sup>, MD, Elizabeth Schiffman<sup>h</sup>, MPH, Theresa Kittle<sup>i</sup>, MPH, Michelle Khau<sup>j</sup>, Alexander Davidson<sup>k</sup>, MPH, Julia Latash<sup>k</sup>, MPH, Courtney Dewart<sup>l,r</sup>, PhD, Casey Van Woerkom<sup>m</sup>, MPH, Dakota C. Matson<sup>m</sup>, MS, Linda Bell<sup>n</sup>, MD, Abdoulaye Diedhiou<sup>n</sup>, MD, PhD, Michelle D. Fiscus<sup>o</sup>, MD, Angela C. Dunn<sup>p</sup>, MD, MPH, Sandy Althomsons<sup>q</sup>, MA, MHS, Claire P. Mattison<sup>q</sup>, MPH, Allison D. Miller<sup>q</sup>, MPH, and Lalita Priyamvada<sup>q</sup>, PhD</p><p id="P58"><sup>a</sup>Arizona Department of Health Services; <sup>b</sup>California Department of Public Health; <sup>c</sup>Los Angeles County Department of Public Health; <sup>d</sup>Colorado Department of Public Health and Environment; <sup>e</sup>Georgia Department of Public Health; <sup>f</sup>Indiana Department of Health; <sup>g</sup>Kansas Department of Health and Environment; <sup>h</sup>Minnesota Department of Health; <sup>i</sup>Mississippi State Department of Health; <sup>j</sup>Nevada Department of Health and Human Services; <sup>k</sup>New York City Department of Health and Mental Hygiene; <sup>l</sup>Ohio Department of Health; <sup>m</sup>Oklahoma State Department of Health; <sup>n</sup>South Carolina Department of Health and Environmental Control; <sup>o</sup>Tennessee Department of Health; <sup>p</sup>Utah Department of Health; <sup>q</sup>CDC COVID-19 Response Team; <sup>r</sup>Epidemic Intelligence Service, CDC</p></app></app-group><glossary><title>Abbreviations:</title><def-list><def-item><term>BMI</term><def><p id="P61">Body mass index</p></def></def-item><def-item><term>CDC</term><def><p id="P62">US Centers for Disease Control and Prevention</p></def></def-item><def-item><term>COVID-19</term><def><p id="P63">coronavirus disease 2019</p></def></def-item><def-item><term>ESR</term><def><p id="P64">erythrocyte sedimentation rate</p></def></def-item><def-item><term>LDH</term><def><p id="P65">lactate dehydrogenase</p></def></def-item><def-item><term>ICU</term><def><p id="P66">intensive care unit</p></def></def-item><def-item><term>IQR</term><def><p id="P67">interquartile range</p></def></def-item><def-item><term>MIS-C</term><def><p id="P68">multisystem inflammatory syndrome in children</p></def></def-item><def-item><term>Research Electronic Data Capture</term><def><p id="P69">REDCap</p></def></def-item><def-item><term>RR</term><def><p id="P70">respiratory rate</p></def></def-item><def-item><term>SARS-CoV-2</term><def><p id="P71">severe acute respiratory system coronavirus 2</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Ludvigsson</surname><given-names>JF</given-names></name>. <article-title>Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults</article-title>. <source>Acta Paediatr</source>. <year>2020</year>;<volume>109</volume>(<issue>6</issue>):<fpage>1088</fpage>&#x02013;<lpage>1095</lpage>. doi:<pub-id pub-id-type="doi">10.1111/apa.15270</pub-id><pub-id pub-id-type="pmid">32202343</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Peres</surname><given-names>TG</given-names></name>, <name><surname>Silva</surname><given-names>MVF</given-names></name>, <name><surname>Camargos</surname><given-names>P</given-names></name>. <article-title>What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases</article-title>. <source>Pediatr Pulmonol</source>. <year>2020</year>;<volume>55</volume>(<issue>8</issue>):<fpage>2115</fpage>&#x02013;<lpage>2127</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ppul.24869</pub-id><pub-id pub-id-type="pmid">32519809</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>LC</given-names></name>, <name><surname>Razzaghi</surname><given-names>H</given-names></name>, <name><surname>Burrows</surname><given-names>EK</given-names></name>, <etal/>
<article-title>Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States</article-title>. <source>JAMA Pediatr</source>. <year>2021</year>;<volume>175</volume>(<issue>2</issue>):<fpage>176</fpage>&#x02013;<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.5052</pub-id><pub-id pub-id-type="pmid">33226415</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Preston</surname><given-names>LE</given-names></name>, <name><surname>Chevinsky</surname><given-names>JR</given-names></name>, <name><surname>Kompaniyets</surname><given-names>L</given-names></name>, <etal/>
<article-title>Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19</article-title>. <source>JAMA Netw open</source>. <year>2021</year>;<volume>4</volume>(<issue>4</issue>):<fpage>e215298</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.5298</pub-id><pub-id pub-id-type="pmid">33835179</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>L</given-names></name>, <name><surname>Whitaker</surname><given-names>M</given-names></name>, <name><surname>O&#x02019;Halloran</surname><given-names>A</given-names></name>, <etal/>
<article-title>Hospitalization Rates and Characteristics of Children Aged &#x0003c;18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2020</year>;<volume>69</volume>(<issue>32</issue>):<fpage>1081</fpage>&#x02013;<lpage>1088</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm6932e3</pub-id><pub-id pub-id-type="pmid">32790664</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><collab>CDC COVID-19 Response Team</collab>. <article-title>Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2020</year>;<volume>69</volume>(<issue>14</issue>):<fpage>422</fpage>&#x02013;<lpage>426</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm6914e4</pub-id><pub-id pub-id-type="pmid">32271728</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="webpage"><collab>CDC</collab>. <source>Coronavirus Disease 2019 (COVID-19): CDC Data Tracker. United States COVID-19 Cases and Deaths by States</source>.; <year>2021</year>. <comment><ext-link xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html" ext-link-type="uri">https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html</ext-link></comment></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Eisen</surname><given-names>RJ</given-names></name>, <name><surname>Eisen</surname><given-names>L</given-names></name>, <name><surname>Ogden</surname><given-names>NH</given-names></name>, <name><surname>Beard</surname><given-names>CB</given-names></name>. <article-title>Linkages of weather and climate with Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae), enzootic transmission of Borrelia burgdorferi, and lyme disease in North America</article-title>. <source>J Med Entomol</source>. <year>2016</year>;<volume>53</volume>(<issue>2</issue>):<fpage>250</fpage>&#x02013;<lpage>261</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jme/tjv199</pub-id><pub-id pub-id-type="pmid">26681789</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>G&#x000f6;tzinger</surname><given-names>F</given-names></name>, <name><surname>Santiago-Garc&#x000ed;a</surname><given-names>B</given-names></name>, <name><surname>Noguera-Juli&#x000e1;n</surname><given-names>A</given-names></name>, <etal/>
<article-title>COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study</article-title>. <source>Lancet Child Adolesc Heal</source>. <year>2020</year>;<volume>4</volume>(<issue>9</issue>):<fpage>653</fpage>&#x02013;<lpage>661</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2352-4642(20)30177-2</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Ko</surname><given-names>JY</given-names></name>, <name><surname>Danielson</surname><given-names>ML</given-names></name>, <name><surname>Town</surname><given-names>M</given-names></name>, <etal/>
<article-title>Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System</article-title>. <source>Clin Infect Dis</source>. <comment>Published online September 18, 2020.</comment> doi:<pub-id pub-id-type="doi">10.1093/cid/ciaa1419</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Shekerdemian</surname><given-names>LS</given-names></name>, <name><surname>Mahmood</surname><given-names>NR</given-names></name>, <name><surname>Wolfe</surname><given-names>KK</given-names></name>, <etal/>
<article-title>Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units</article-title>. <source>JAMA Pediatr</source>. <year>2020</year>;<volume>174</volume>(<issue>9</issue>):<fpage>868</fpage>&#x02013;<lpage>873</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.1948</pub-id><pub-id pub-id-type="pmid">32392288</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Feldstein</surname><given-names>LR</given-names></name>, <name><surname>Rose</surname><given-names>EB</given-names></name>, <name><surname>Horwitz</surname><given-names>SM</given-names></name>, <etal/>
<article-title>Multisystem Inflammatory Syndrome in U.S. Children and Adolescents</article-title>. <source>N Engl J Med</source>. <year>2020</year>;<volume>383</volume>(<issue>4</issue>):<fpage>334</fpage>&#x02013;<lpage>346</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2021680</pub-id><pub-id pub-id-type="pmid">32598831</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Leidman</surname><given-names>E</given-names></name>, <name><surname>Duca</surname><given-names>LM</given-names></name>, <name><surname>Omura</surname><given-names>JD</given-names></name>, <name><surname>Proia</surname><given-names>K</given-names></name>, <name><surname>Stephens</surname><given-names>JW</given-names></name>, <name><surname>Sauber-Schatz</surname><given-names>EK</given-names></name>. <article-title>COVID-19 Trends Among Persons Aged 0&#x02013;24 Years - United States, March 1-December 12, 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2021</year>;<volume>70</volume>(<issue>3</issue>):<fpage>88</fpage>&#x02013;<lpage>94</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm7003e1</pub-id><pub-id pub-id-type="pmid">33476314</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Levin</surname><given-names>Z</given-names></name>, <name><surname>Choyke</surname><given-names>K</given-names></name>, <name><surname>Georgiou</surname><given-names>A</given-names></name>, <name><surname>Sen</surname><given-names>S</given-names></name>, <name><surname>Karaca-Mandic</surname><given-names>P</given-names></name>. <article-title>Trends in Pediatric Hospitalizations for Coronavirus Disease 2019</article-title>. <source>JAMA Pediatr</source>. <comment>Published online January 11, 2021.</comment> doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.5535</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Bixler</surname><given-names>D</given-names></name>, <name><surname>Miller</surname><given-names>AD</given-names></name>, <name><surname>Mattison</surname><given-names>CP</given-names></name>, <etal/>
<article-title>SARS-CoV-2-Associated Deaths Among Persons Aged &#x0003c;21 Years - United States, February 12-July 31, 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2020</year>;<volume>69</volume>(<issue>37</issue>):<fpage>1324</fpage>&#x02013;<lpage>1329</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm6937e4</pub-id><pub-id pub-id-type="pmid">32941417</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="webpage"><collab>Council of State and Territorial Epidemiologists</collab>. <source>Standardized Surveillance Case Definition and National Notification for 2019 Novel Coronavirus Disease (COVID-19)</source>.; <year>2020</year>. <comment><ext-link xlink:href="https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf" ext-link-type="uri">https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf</ext-link></comment></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="webpage"><collab>CDC</collab>. <source>Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19)</source>.; <year>2020</year>. doi:<comment><ext-link xlink:href="https://emergency.cdc.gov/han/2020/han00432.asp" ext-link-type="uri">https://emergency.cdc.gov/han/2020/han00432.asp</ext-link></comment></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>PA</given-names></name>, <name><surname>Taylor</surname><given-names>R</given-names></name>, <name><surname>Thielke</surname><given-names>R</given-names></name>, <name><surname>Payne</surname><given-names>J</given-names></name>, <name><surname>Gonzalez</surname><given-names>N</given-names></name>, <name><surname>Conde</surname><given-names>JG</given-names></name>. <article-title>Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support</article-title>. <source>J Biomed Inform</source>. <year>2009</year>;<volume>42</volume>(<issue>2</issue>):<fpage>377</fpage>&#x02013;<lpage>381</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbi.2008.08.010</pub-id><pub-id pub-id-type="pmid">18929686</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>PA</given-names></name>, <name><surname>Taylor</surname><given-names>R</given-names></name>, <name><surname>Minor</surname><given-names>BL</given-names></name>, <etal/>
<article-title>The REDCap consortium: Building an international community of software platform partners</article-title>. <source>J Biomed Inform</source>. <year>2019</year>;<volume>95</volume>:<fpage>103208</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbi.2019.103208</pub-id><pub-id pub-id-type="pmid">31078660</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="other"><source>See e.g., 45 C.F.R. Part 46.102(l)(2), 21 C.F.R. Part 56; 42 U.S.C. &#x000a7;241(d); 5 U.S.C. &#x000a7;552a; 44 U.S.C. &#x000a7;3501 et Seq</source>.</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="book"><collab>The Johns Hopkins Hospital</collab>, <name><surname>Kahl</surname><given-names>L</given-names></name>, <name><surname>Hughes</surname><given-names>HK</given-names></name>. <source>The Harriet Lane Handbook</source>. <edition>21st</edition> ed. <publisher-name>Elsevier</publisher-name>; <year>2018</year>.</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="webpage"><collab>Seattle Children&#x02019;s Hospital</collab>. <source>Seattle Children&#x02019;s Hospital online test catalog</source>. <comment>Published 2021.</comment>
<comment><ext-link xlink:href="https://www.seattlechildrenslab.testcatalog.org" ext-link-type="uri">https://www.seattlechildrenslab.testcatalog.org</ext-link></comment></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>Clinical Growth Charts</source>. <comment>Published 2021.</comment>
<comment><ext-link xlink:href="https://www.cdc.gov/growthcharts/clinical_charts.htm" ext-link-type="uri">https://www.cdc.gov/growthcharts/clinical_charts.htm</ext-link></comment></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><article-title>WHO Programme for the Control of Acute Respiratory Infections</article-title>. <source>Management of the Young Child with Acute Respiratory Infection: Supervisory Skills</source>.; <year>1991</year>.</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Tsankov</surname><given-names>BK</given-names></name>, <name><surname>Allaire</surname><given-names>JM</given-names></name>, <name><surname>Irvine</surname><given-names>MA</given-names></name>, <etal/>
<article-title>Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis</article-title>. <source>Int J Infect Dis</source>. <year>2021</year>;<volume>103</volume>:<fpage>246</fpage>&#x02013;<lpage>256</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijid.2020.11.163</pub-id><pub-id pub-id-type="pmid">33227520</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Verma</surname><given-names>S</given-names></name>, <name><surname>Lumba</surname><given-names>R</given-names></name>, <name><surname>Dapul</surname><given-names>HM</given-names></name>, <etal/>
<article-title>Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area</article-title>. <source>Hosp Pediatr</source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>71</fpage>&#x02013;<lpage>78</lpage>. doi:<pub-id pub-id-type="doi">10.1542/hpeds.2020-001917</pub-id><pub-id pub-id-type="pmid">33033078</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>L</given-names></name>, <name><surname>Garg</surname><given-names>S</given-names></name>, <name><surname>O&#x02019;Halloran</surname><given-names>A</given-names></name>, <etal/>
<article-title>Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)</article-title>. <source>Clin Infect Dis</source>. <comment>Published online July 16, 2020.</comment> doi:<pub-id pub-id-type="doi">10.1093/cid/ciaa1012</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Killerby</surname><given-names>ME</given-names></name>, <name><surname>Link-Gelles</surname><given-names>R</given-names></name>, <name><surname>Haight</surname><given-names>SC</given-names></name>, <etal/>
<article-title>Characteristics Associated with Hospitalization Among Patients with COVID-19 - Metropolitan Atlanta, Georgia, March-April 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2020</year>;<volume>69</volume>(<issue>25</issue>):<fpage>790</fpage>&#x02013;<lpage>794</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm6925e1</pub-id><pub-id pub-id-type="pmid">32584797</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Karaca-Mandic</surname><given-names>P</given-names></name>, <name><surname>Georgiou</surname><given-names>A</given-names></name>, <name><surname>Sen</surname><given-names>S</given-names></name>. <article-title>Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States</article-title>. <source>JAMA Intern Med</source>. <year>2021</year>;<volume>181</volume>(<issue>1</issue>):<fpage>131</fpage>&#x02013;<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamainternmed.2020.3857</pub-id><pub-id pub-id-type="pmid">32804192</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Bhumbra</surname><given-names>S</given-names></name>, <name><surname>Malin</surname><given-names>S</given-names></name>, <name><surname>Kirkpatrick</surname><given-names>L</given-names></name>, <etal/>
<article-title>Clinical Features of Critical Coronavirus Disease 2019 in Children</article-title>. <source>Pediatr Crit Care Med</source>. <year>2020</year>;<volume>21</volume>(<issue>10</issue>):<fpage>e948</fpage>&#x02013;<lpage>e953</lpage>. doi:<pub-id pub-id-type="doi">10.1097/PCC.0000000000002511</pub-id><pub-id pub-id-type="pmid">32639466</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Javalkar</surname><given-names>K</given-names></name>, <name><surname>Robson</surname><given-names>VK</given-names></name>, <name><surname>Gaffney</surname><given-names>L</given-names></name>, <etal/>
<article-title>Socioeconomic and Racial/Ethnic Disparities in Multisystem Inflammatory Syndrome</article-title>. <source>Pediatrics</source>. <comment>Published online February 18, 2021</comment>:<fpage>e2020039933</fpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2020-039933</pub-id><pub-id pub-id-type="pmid">33602802</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>EH</given-names></name>, <name><surname>Kepler</surname><given-names>KL</given-names></name>, <name><surname>Geevarughese</surname><given-names>A</given-names></name>, <etal/>
<article-title>Race/Ethnicity Among Children With COVID-19-Associated Multisystem Inflammatory Syndrome</article-title>. <source>JAMA Netw open</source>. <year>2020</year>;<volume>3</volume>(<issue>11</issue>):<fpage>e2030280</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.30280</pub-id><pub-id pub-id-type="pmid">33252688</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="webpage"><collab>CDC</collab>. <source>COVID-19 Racial and Ethnic Health Disparities</source>.; <year>2021</year>. <comment><ext-link xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/racial-ethnic-disparities/what-we-do.html" ext-link-type="uri">https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/racial-ethnic-disparities/what-we-do.html</ext-link></comment></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Zablotsky</surname><given-names>B</given-names></name>, <name><surname>Black</surname><given-names>LI</given-names></name>, <name><surname>Blumberg</surname><given-names>SJ</given-names></name>. <article-title>Estimated Prevalence of Children With Diagnosed Developmental Disabilities in the United States, 2014&#x02013;2016</article-title>. <source>NCHS Data Brief</source>. <year>2017</year>;(<issue>291</issue>):<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <comment><ext-link xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/29235982" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/pubmed/29235982</ext-link></comment></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Ogden</surname><given-names>CL</given-names></name>, <name><surname>Carroll</surname><given-names>MD</given-names></name>, <name><surname>Kit</surname><given-names>BK</given-names></name>, <name><surname>Flegal</surname><given-names>KM</given-names></name>. <article-title>Prevalence of obesity and trends in body mass index among US children and adolescents, 1999&#x02013;2010</article-title>. <source>JAMA</source>. <year>2012</year>;<volume>307</volume>(<issue>5</issue>):<fpage>483</fpage>&#x02013;<lpage>490</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2012.40</pub-id><pub-id pub-id-type="pmid">22253364</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Ward</surname><given-names>E</given-names></name>, <name><surname>DeSantis</surname><given-names>C</given-names></name>, <name><surname>Robbins</surname><given-names>A</given-names></name>, <name><surname>Kohler</surname><given-names>B</given-names></name>, <name><surname>Jemal</surname><given-names>A</given-names></name>. <article-title>Childhood and adolescent cancer statistics, 2014</article-title>. <source>CA Cancer J Clin</source>. <year>2014</year>;<volume>64</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02013;<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.3322/caac.21219</pub-id><pub-id pub-id-type="pmid">24488779</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>A</given-names></name>, <name><surname>Serban</surname><given-names>N</given-names></name>, <name><surname>Fitzpatrick</surname><given-names>A</given-names></name>. <article-title>Asthma Prevalence Among Medicaid-Enrolled Children</article-title>. <source>J allergy Clin Immunol Pract</source>. <year>2019</year>;<volume>7</volume>(<issue>4</issue>):<fpage>1207</fpage>&#x02013;<lpage>1213.e4</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaip.2018.10.008</pub-id><pub-id pub-id-type="pmid">30339856</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>DeBiasi</surname><given-names>RL</given-names></name>, <name><surname>Song</surname><given-names>X</given-names></name>, <name><surname>Delaney</surname><given-names>M</given-names></name>, <etal/>
<article-title>Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region</article-title>. <source>J Pediatr</source>. <year>2020</year>;<volume>223</volume>:<fpage>199</fpage>&#x02013;<lpage>203.e1</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2020.05.007</pub-id><pub-id pub-id-type="pmid">32405091</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Turk</surname><given-names>MA</given-names></name>, <name><surname>Landes</surname><given-names>SD</given-names></name>, <name><surname>Formica</surname><given-names>MK</given-names></name>, <name><surname>Goss</surname><given-names>KD</given-names></name>. <article-title>Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis</article-title>. <source>Disabil Health J</source>. <year>2020</year>;<volume>13</volume>(<issue>3</issue>):<fpage>100942</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.dhjo.2020.100942</pub-id><pub-id pub-id-type="pmid">32473875</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Chao</surname><given-names>JY</given-names></name>, <name><surname>Derespina</surname><given-names>KR</given-names></name>, <name><surname>Herold</surname><given-names>BC</given-names></name>, <etal/>
<article-title>Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City</article-title>. <source>J Pediatr</source>. <year>2020</year>;<volume>223</volume>:<fpage>14</fpage>&#x02013;<lpage>19.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2020.05.006</pub-id><pub-id pub-id-type="pmid">32407719</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Posfay-Barbe</surname><given-names>KM</given-names></name>, <name><surname>Wagner</surname><given-names>N</given-names></name>, <name><surname>Gauthey</surname><given-names>M</given-names></name>, <etal/>
<article-title>COVID-19 in Children and the Dynamics of Infection in Families</article-title>. <source>Pediatrics</source>. <year>2020</year>;<volume>146</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.1542/peds.2020-1576</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Honein</surname><given-names>MA</given-names></name>, <name><surname>Barrios</surname><given-names>LC</given-names></name>, <name><surname>Brooks</surname><given-names>JT</given-names></name>. <article-title>Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection</article-title>. <source>JAMA</source>. <comment>Published online January 26, 2021.</comment> doi:<pub-id pub-id-type="doi">10.1001/jama.2021.0374</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Dawson</surname><given-names>P</given-names></name>, <name><surname>Worrell</surname><given-names>MC</given-names></name>, <name><surname>Malone</surname><given-names>S</given-names></name>, <etal/>
<article-title>Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies &#x02014; St. Louis County and City of Springfield, Missouri, December 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2021</year>;<volume>70</volume>(<issue>12</issue>). doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm7012e4</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Hershow</surname><given-names>RB</given-names></name>, <name><surname>Wu</surname><given-names>K</given-names></name>, <name><surname>Lewis</surname><given-names>NM</given-names></name>, <etal/>
<article-title>Low SARS-CoV-2 Transmission in Elementary Schools &#x02014; Salt Lake County, Utah, December 3, 2020&#x02013;January 31, 2021</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2021</year>;<volume>70</volume>(<issue>12</issue>). doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm7012e3</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Doyle</surname><given-names>T</given-names></name>, <name><surname>Kendrick</surname><given-names>K</given-names></name>, <name><surname>Troelstrup</surname><given-names>T</given-names></name>, <etal/>
<article-title>COVID-19 in Primary and Secondary School Settings During the First Semester of School Reopening &#x02014; Florida, August&#x02013;December 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2021</year>;<volume>70</volume>(<issue>12</issue>). doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm7012e2</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Falk</surname><given-names>A</given-names></name>, <name><surname>Benda</surname><given-names>A</given-names></name>, <name><surname>Falk</surname><given-names>P</given-names></name>, <name><surname>Steffen</surname><given-names>S</given-names></name>, <name><surname>Wallace</surname><given-names>Z</given-names></name>, <name><surname>H&#x000f8;eg</surname><given-names>TB</given-names></name>. <article-title>COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2021</year>;<volume>70</volume>(<issue>4</issue>):<fpage>136</fpage>&#x02013;<lpage>140</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm7004e3</pub-id><pub-id pub-id-type="pmid">33507890</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>Zimmerman</surname><given-names>KO</given-names></name>, <name><surname>Akinboyo</surname><given-names>IC</given-names></name>, <name><surname>Brookhart</surname><given-names>MA</given-names></name>, <etal/>
<article-title>Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools</article-title>. <source>Pediatrics</source>. <comment>Published online January 8, 2021.</comment> doi:<pub-id pub-id-type="doi">10.1542/peds.2020-048090</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Gold</surname><given-names>JAW</given-names></name>, <name><surname>Gettings</surname><given-names>JR</given-names></name>, <name><surname>Kimball</surname><given-names>A</given-names></name>, <name><surname>Franklin</surname><given-names>R</given-names></name>, <name><surname>Rivera</surname><given-names>G</given-names></name>. <source>Clusters of SARS-CoV-2 Infection Among Elementary School Educators and Students in One School District &#x02014; Georgia, December 2020 &#x02013; January 2021</source>. <year>2021</year>;<volume>70</volume>(<issue>December 2020</issue>):<fpage>2</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="webpage"><collab>COVID-19 Treatment Guidelines Panel</collab>. <source>Coronavirus Disease 2019 (COVID-19) Treatment Guidelines: Special Considerations in Children</source>. <comment><ext-link xlink:href="https://www.covid19treatmentguidelines.nih.gov/special-populations/children/" ext-link-type="uri">https://www.covid19treatmentguidelines.nih.gov/special-populations/children/</ext-link></comment></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name><surname>Gundlapalli</surname><given-names>AV</given-names></name>, <name><surname>Lavery</surname><given-names>AM</given-names></name>, <name><surname>Boehmer</surname><given-names>TK</given-names></name>, <etal/>
<article-title>Death Certificate&#x02013;Based ICD-10 Diagnosis Codes for COVID-19 Mortality Surveillance &#x02014; United States, January&#x02013;December 2020</article-title>. <source>MMWR Surveill Summ</source>. <year>2021</year>;<volume>70</volume>(<issue>14</issue>):<fpage>523</fpage>&#x02013;<lpage>527</lpage>. doi:<pub-id pub-id-type="doi">10.15585/mmwr.mm7014e2</pub-id></mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="webpage"><source>Pfizer-BioNTech COVID-19 Vaccine EUA Amendment Review Memorandum</source>; <year>2021</year>. <comment><ext-link xlink:href="https://www.fda.gov/media/148542/download" ext-link-type="uri">https://www.fda.gov/media/148542/download</ext-link></comment></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P72">Study flow diagram.</p><p id="P73">Abbreviation: MIS-C, Multisystem inflammatory syndrome in children</p><p id="P74">* The interim COVID-19 case definition published by the Council of State and Territorial Epidemiologists on August 5, 2020 was used to classify cases as confirmed or probable.<sup><xref rid="R16" ref-type="bibr">16</xref></sup></p><p id="P75">&#x02020;Cases met MIS-C criteria if they fulfilled the case definition published in the CDC Health Alert Network Health Advisory on May 14, 2020.<sup><xref rid="R17" ref-type="bibr">17</xref></sup></p></caption><graphic xlink:href="nihms-1860632-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p id="P76">Histogram showing the age distribution for all decedents (A), those who died in the hospital (B), and those who died at home or in the emergency department (C).</p></caption><graphic xlink:href="nihms-1860632-f0002" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1.</label><caption><p id="P77">Demographic characteristics of all decedents (<italic toggle="yes">n</italic> = 112)</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="middle" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th></tr><tr><th colspan="3" align="left" valign="middle" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="center" valign="top" rowspan="1" colspan="1">63</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">37</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Age in years (Median, Interquartile Range)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">17, 8.5&#x02013;19</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003c;1</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;1&#x02013;4</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;5&#x02013;9</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">11</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;10&#x02013;13</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">11</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;14&#x02013;17</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;18&#x02013;20</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">43</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Race/Ethnicity</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;White (non-Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Black, non-Hispanic</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">28</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hispanic</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;American Indian or Alaska Native (non-Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Asian or Pacific Islander (non-Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Geographic Region</bold>
<xref rid="TFN1" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Midwest</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Northeast</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">31</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;South</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">37</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;West</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">21</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p id="P78">Regions based on US Census Bureau regions (<ext-link xlink:href="https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf" ext-link-type="uri">https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf</ext-link>). US territories assigned to Census regions based on their geographic proximity to states assigned to those regions and based on their assignment to standard federal regions (<ext-link xlink:href="https://www.gsa.gov/about-us/gsa-regions" ext-link-type="uri">https://www.gsa.gov/about-us/gsa-regions</ext-link>).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P79">Demographic characteristics for decedents with known multisystem inflammatory syndrome in children (MIS-C) status (<italic toggle="yes">n</italic> = 96)</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="top" rowspan="1">Met MIS-C Criteria<xref rid="TFN2" ref-type="table-fn">*</xref> (<italic toggle="yes">n</italic> = 16)</th><th colspan="2" align="center" valign="top" rowspan="1">Did not Meet MIS-C Criteria (<italic toggle="yes">n</italic> = 80)</th></tr><tr><th colspan="5" align="left" valign="middle" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th></tr><tr><th colspan="5" align="left" valign="middle" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">56</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Age in years (Median, Interquartile Range)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">16, 6&#x02013;19</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">17, 11&#x02013;19</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003c;1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;1&#x02013;4</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;5&#x02013;9</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;10&#x02013;13</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">11</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;14&#x02013;17</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;18&#x02013;20</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Race/Ethnicity</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;White (non-Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Black (non-Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hispanic</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">56</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;American Indian or Alaska Native (non-Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Asian or Pacific Islander (non-Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Geographic Region</bold>
<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Midwest</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Northeast</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">26</td><td align="center" valign="top" rowspan="1" colspan="1">33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;South</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">56</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">29</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;West</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Underlying Medical Conditions</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;None (0)</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Any (&#x02265;1)</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">70</td><td align="center" valign="top" rowspan="1" colspan="1">87</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p id="P80">Cases met MIS-C criteria if they fulfilled the case definition published in the CDC Health Alert Network Health Advisory on May 14, 2020.<sup><xref rid="R17" ref-type="bibr">17</xref></sup></p></fn><fn id="TFN3"><label>&#x02020;</label><p id="P81">Regions based on US Census Bureau regions (<ext-link xlink:href="https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf" ext-link-type="uri">https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf</ext-link>). US territories assigned to Census regions based on their geographic proximity to states assigned to those regions and based on their assignment to standard federal regions (<ext-link xlink:href="https://www.gsa.gov/about-us/gsa-regions" ext-link-type="uri">https://www.gsa.gov/about-us/gsa-regions</ext-link>).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3.</label><caption><p id="P82">Disease classification and hospitalization status for decedents with clinical information (<italic toggle="yes">n</italic> = 112)</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th></tr><tr><th colspan="3" align="left" valign="middle" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>COVID-19 Classification</bold>
<xref rid="TFN5" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Confirmed</td><td align="center" valign="top" rowspan="1" colspan="1">108</td><td align="center" valign="top" rowspan="1" colspan="1">96%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Probable</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>MIS-C Classification</bold>
<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Met MIS-C Criteria</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Did not Meet MIS-C Criteria</td><td align="center" valign="top" rowspan="1" colspan="1">80</td><td align="center" valign="top" rowspan="1" colspan="1">71%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown MIS-C Status</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Hospitalization Status</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hospitalized</td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">62%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Hospitalized</td><td align="center" valign="top" rowspan="1" colspan="1">43</td><td align="center" valign="top" rowspan="1" colspan="1">38%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Admitted to Intensive Care Unit</bold>
<xref rid="TFN7" ref-type="table-fn">&#x02021;</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">49%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Applicable</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">42%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Outpatient Medical Visits Prior to Death</bold>
<xref rid="TFN8" ref-type="table-fn">**</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Emergency Department Visit Only</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Clinic or Urgent Care Visit Only</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">22%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Both Emergency Department and Clinic or Urgent Care Visit</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;None</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">31%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Location of Death</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hospital</td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">62%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Emergency Department</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Home</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">16%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hospice Care</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>COVID-19 Contribution to Death</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Underlying</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">43%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Contributing Factor</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown Death Certificate not Available</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Death Certificate not Available</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">34%</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p id="P83">Abbreviation: MIS-C, Multisystem inflammatory syndrome in children</p></fn><fn id="TFN5"><label>*</label><p id="P84">The interim COVID-19 case definition published by the Council of State and Territorial Epidemiologists on August 5, 2020 was used to classify cases as confirmed or probable.<sup><xref rid="R16" ref-type="bibr">16</xref></sup></p></fn><fn id="TFN6"><label>&#x02020;</label><p id="P85">Cases met MIS-C criteria if they fulfilled the case definition published in the CDC Health Alert Network Health Advisory on May 14, 2020.<sup><xref rid="R17" ref-type="bibr">17</xref></sup></p></fn><fn id="TFN7"><label>&#x02021;</label><p id="P86">Restricted to those patients who were admitted to the hospital</p></fn><fn id="TFN8"><label>**</label><p id="P87">Defined as seeking care in an emergency department, urgent care center, or outpatient clinic &#x02265;1 day prior to death or hospitalization, whichever came first</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4.</label><caption><p id="P88">Underlying medical conditions for all decedents, decedents who met MIS-C criteria, and decedents who did not meet MIS-C criteria (<italic toggle="yes">n</italic> = 112)</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="6" align="left" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="middle" rowspan="1">All Decedents (<italic toggle="yes">n</italic> = 112)</th><th colspan="2" align="center" valign="middle" rowspan="1">Met MIS-C Criteria (<italic toggle="yes">n</italic> = 16)</th><th colspan="2" align="center" valign="middle" rowspan="1">Did not Meet MIS-C Criteria (<italic toggle="yes">n</italic> = 80)</th></tr><tr><th colspan="7" align="center" valign="middle" rowspan="1">
<hr/>
</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th></tr><tr><th colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Number of Underlying Medical Conditions</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;None</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">31%</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;1</td><td align="center" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;2</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">20%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">25%</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;3</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">16%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;4</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">9%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">10%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02265;5</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">22%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Metabolic and Endocrine</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>51</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>46%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>7</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>44%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>39</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>49%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Obesity</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">42%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">31%</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">46%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Diabetes Mellitus<xref rid="TFN9" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">10%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">11%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN10" ref-type="table-fn">a</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">11%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">135</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">11%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Neurologic and Developmental</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>37</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>33%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>5</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>31%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>24</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>30%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Developmental Disorder</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">22%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Seizure disorder</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">15%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN11" ref-type="table-fn">b</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">18%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Respiratory</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>35</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>31%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>38%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>24</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>30%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Asthma or Reactive Airway Disease</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">31%</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN12" ref-type="table-fn">c</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Cardiovascular</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>20</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>18%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>19%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>14</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>18%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">9%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">11%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Congenital Heart Disease</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cardiomyopathy</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">35%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN13" ref-type="table-fn">d</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Gastrointestinal/Hepatic</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>21</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>19%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>4</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>25%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>12</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>15%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Dependent on gastric tube feedings</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">16%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">25%</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Gastroesophageal Reflux</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN14" ref-type="table-fn">e</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Malignancy</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>13</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>12%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>8</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>10%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hematologic Malignancy</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-hematologic Malignancy</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Immunologic</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>12</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>11%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>10</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>13%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Immunosuppressive Therapy</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Solid organ or Stem Cell Transplant Recipient</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN15" ref-type="table-fn">f</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Genetic</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>12</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>11%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>2</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>13%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>7</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>9%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Chromosomal Abnormality<sup><xref rid="TFN16" ref-type="table-fn">g</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN17" ref-type="table-fn">h</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Hematologic</bold>
<sup>
<xref rid="TFN18" ref-type="table-fn">i</xref>
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>8</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>7%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>8%</bold>
</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Psychiatric</bold>
<sup>
<xref rid="TFN19" ref-type="table-fn">j</xref>
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>8</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>7%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>8%</bold>
</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Substance Use</bold>
<sup>
<xref rid="TFN20" ref-type="table-fn">k</xref>
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>5%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>8%</bold>
</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Renal</bold>
<sup>
<xref rid="TFN21" ref-type="table-fn">l</xref>
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>5%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>5</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6%</bold>
</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Dermatologic</bold>
<sup>
<xref rid="TFN22" ref-type="table-fn">m</xref>
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>5</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>4%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>6%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>4%</bold>
</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Rheumatologic</bold>
<sup>
<xref rid="TFN23" ref-type="table-fn">n</xref>
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>3%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>4%</bold>
</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Other</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>13</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>12%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>2</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>13%</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>9</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>11%</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sleep Apnea</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other<sup><xref rid="TFN24" ref-type="table-fn">o</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td></tr></tbody></table><table-wrap-foot><fn id="TFN9"><label>*</label><p id="P89">Includes both Type 1 and Type 2</p></fn><fn id="TFN10"><label>a</label><p id="P90">Includes hypothyroidism (4), panhypopituitarism (1), diabetes insipidus (1), hypothalamic-pituitary axis dysfunction (1), adrenal insufficiency (1), osteoporosis (1), and Other/Unknown (4)</p></fn><fn id="TFN11"><label>b</label><p id="P91">Includes autism (5), blindness (3), microcephaly (2), Charcot-Marie-Tooth (2), chronic inflammatory demyelinating polyradiculoneuropathy (1), hearing loss (1), septo-optic dysplasia (1), migraine (1), ataxia telangiectasia (1), hydrocephalus (1), and Other/Unknown (2)</p></fn><fn id="TFN12"><label>c</label><p id="P92">Includes bronchopulmonary dysplasia (1), Interstitial Lung Disease (1), and Other/Unknown (2)</p></fn><fn id="TFN13"><label>d</label><p id="P93">Includes lipid disorder (5), Wolff-Parkinson-White (1), and Other/Unknown (9).</p></fn><fn id="TFN14"><label>e</label><p id="P94">Includes history of necrotizing enterocolitis (2), history of malrotation (1), celiac disease (1), dysphagia (1), and history of liver transplantation (1).</p></fn><fn id="TFN15"><label>f</label><p id="P95">Includes Graft vs Host Disease (1) and Other/Unknown (6).</p></fn><fn id="TFN16"><label>g</label><p id="P96">Includes trisomy 13 (2), trisomy 21 (1), and unspecified chromosomal deletion (2).</p></fn><fn id="TFN17"><label>h</label><p id="P97">Includes congenital muscular dystrophy (2), cobalamin C deficiency (1), metachromatic leukodystrophy (1), neurofibromatosis (1), Rett Syndrome (1), and overgrowth syndrome (1).</p></fn><fn id="TFN18"><label>i</label><p id="P98">Includes anemia (4), deep vein thrombosis (2), sickle cell anemia (1), recurrent thrombosis (1), clotting disorder NOS (1), and Other/Unknown (1).</p></fn><fn id="TFN19"><label>j</label><p id="P99">Includes anxiety (1), major depressive disorder (1), history of suicide attempt (1), and Other/Unknown (6).</p></fn><fn id="TFN20"><label>k</label><p id="P100">Includes cigarette smoking (1), vaping (1), and unspecified substance abuse or misuse (5).</p></fn><fn id="TFN21"><label>l</label><p id="P101">Includes end-stage renal disease (2), neurogenic bladder (1), renal cyst (1), renal hyperplasia (1), history of continuous renal replacement therapy during a prior hospitalization (1), and Other/Unknown (1).</p></fn><fn id="TFN22"><label>m</label><p id="P102">Includes eczema (5).</p></fn><fn id="TFN23"><label>n</label><p id="P103">Includes juvenile rheumatoid arthritis (1), CREST syndrome (1), and systemic lupus erythematosus (1).</p></fn><fn id="TFN24"><label>o</label><p id="P104">Includes glaucoma (1), cleft palate (1), Herpes Simplex 1 infection (1), congenital cytomegalovirus (1), malnutrition (1), and Other/Unknown (1).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T5"><label>Table 5.</label><caption><p id="P105">Selected medical interventions and complications for all decedents admitted to the hospital, those admitted to the hospital who met MIS-C criteria, and those admitted to the hospital who did not meet MIS-C criteria</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="6" align="left" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="middle" rowspan="1">All Decedents<xref rid="TFN25" ref-type="table-fn">*</xref></th><th colspan="2" align="center" valign="middle" rowspan="1">MIS-C (<italic toggle="yes">n</italic> = 14)</th><th colspan="2" align="center" valign="middle" rowspan="1">Not MIS-C<xref rid="TFN26" ref-type="table-fn">&#x02020;</xref></th></tr><tr><th colspan="7" align="center" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">%</th></tr><tr><th colspan="7" align="left" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Respiratory Support</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-invasive positive-pressure ventilation</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">27%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">27%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Endotracheal intubation and mechanical ventilation</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">75%</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">79%</td><td align="center" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">71%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Extracorporeal membrane oxygenation therapy</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">10%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Medical Interventions and Therapeutics</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Anticoagulation</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">62%</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">64%</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">61%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Vasopressor and/or inotrope support</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">60%</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">57%</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">61%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Corticosteroids</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">45%</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">50%</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">54%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Remdesivir</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">35%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">36%</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Azithromycin</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">37%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">41%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cardiopulmonary resuscitation</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">32%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">34%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Convalescent plasma therapy</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">27%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">43%</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">20%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hydroxychloroquine</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">27%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Immune modulators (anakinra, canakinumab, tocilizumab)</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">25%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">43%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">15%</td></tr><tr><td colspan="7" align="left" valign="middle" rowspan="1">
<hr/>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Complications During Hospital Course</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Acute respiratory failure</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">82%</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">57%</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">88%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Shock</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">56%</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">64%</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">52%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Acute Respiratory Distress Syndrome</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">50%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">43%</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">52%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sepsis</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">40%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">36%</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">40%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Acute renal failure</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">34%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">36%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cardiac arrhythmia</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">26%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">36%</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">26%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cerebrovascular accident</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Deep vein thrombosis or pulmonary embolism</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Acute liver failure</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Myocarditis</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">5%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2%</td></tr></tbody></table><table-wrap-foot><fn id="TFN25"><label>*</label><p id="P106">Sample size varied by category, with (<italic toggle="yes">n</italic> = 60) for both &#x0201c;Respiratory Support&#x0201d; and &#x0201c;Medical Interventions and Therapeutics&#x0201d;, and (<italic toggle="yes">n</italic> = 62) for &#x0201c;Complications During Hospital Course&#x0201d;</p></fn><fn id="TFN26"><label>&#x02020;</label><p id="P107">Sample size varied by category, with (<italic toggle="yes">n</italic> = 41) for both &#x0201c;Respiratory Support&#x0201d; and &#x0201c;Medical Interventions and Therapeutics&#x0201d;, and (<italic toggle="yes">n</italic> = 42) for &#x0201c;Complications During Hospital Course&#x0201d;</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float"><sec id="S19"><title>What&#x02019;s Known on This Subject</title><p id="P108">Pediatric mortality from SARS-CoV-2 is uncommon. Previous studies have reported risk factors associated with severe COVID-19 disease and MIS-C, and case series from Europe and China have described clinical features of pediatric SARS-CoV-2-associated deaths.</p></sec><sec id="S20"><title>What This Study Adds</title><p id="P109">SARS-CoV-2-associated deaths among persons &#x0003c;21 years of age during February&#x02013;July 2020 occurred predominantly among older adolescent males and Black (non-Hispanic) and Hispanic persons. Obesity, asthma, and developmental disorders were the most commonly reported underlying conditions.</p></sec></boxed-text></floats-group></article>